FDA regulations make it harder to sue drug companies

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

When Can Patients Sue Drug Companies?

Vol. 34 No. 5 • May 2009 • P&T® 243 (see the April issue of P&T, page 175). Ms. Levine sued and received a settlement from the clinic where the drug was administered. She also named Wyeth as a defendant, claiming that the drug’s label should have more clearly instructed clinicians against using an IV push injection. The label, which the FDA had approved, warned about inadvertent intra-arterial ...

متن کامل

Explanations make inconsistencies harder to detect

What role do explanations play in reasoning about inconsistencies? We postulate that when people create explanations, they use them to resolve conflicting information. This hypothesis predicts that inconsistencies should be harder to detect once individuals have in mind an explanation of the inconsistency. We report four experiments that tested this prediction. Experiments 1a and 1b corroborate...

متن کامل

Composition: A Way to Make Proofs Harder

Compositional reasoning about a system means writing its specification as the parallel composition of components and reasoning separately about each component. When distracting language issues are removed and the underlying mathematics is revealed, compositional reasoning is seen to be of little use.

متن کامل

Inspiratory muscle training in difficult to wean patients: work it harder, make it better, do it faster, makes us stronger

Weaning from prolonged mechanical ventilation is a complex, time-consuming process that involves the loss of force/generating capacity of the inspiratory muscle. In their study 'Inspiratory muscle strength training improves the outcome in failure to wean patients: a randomized trial', Martin and colleagues showed that the use of an inspiratory muscle strength program increased the maximal inspi...

متن کامل

FDA considers tightening regulations for direct-to-consumer advertising.

In August, the Pharmaceutical Researchers and Manufacturers of America (PhRMA) sought to curb growing public criticism over its consumer advertising practices by releasing voluntary advertising guidelines. The document stated that drug advertising should serve the public health by “ increasing awareness about diseases ” and “ educating patients about treatment options. ” The voluntary PhRMA gui...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: BMJ

سال: 2006

ISSN: 0959-8138,1468-5833

DOI: 10.1136/bmj.332.7554.1350-b